Reaction
Small Intestinal Haemorrhage reporting signals
As of the last recalculation, Small Intestinal Haemorrhage appears in 1,980 FAERS reports alongside 41 co-occurring drug terms. The strongest observed disproportionality signal is RIVAROXABAN (PRR 18.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rivaroxaban | 314 | 18.7 | 18.7 |
| Micafungin Sodium | 14 | 17.5 | 17.5 |
| Fondaparinux Sodium | 12 | 15.7 | 15.7 |
| Brinzolamide | 10 | 12.2 | 12.2 |
| Pitavastatin Calcium | 10 | 10.3 | 10.3 |
| Dabigatran Etexilate Mesylate | 65 | 9.7 | 9.7 |
| Dabigatran Etexilate | 67 | 9.4 | 9.4 |
| Febuxostat Tablets 40 Mg | 9 | 9.3 | 9.3 |
| Febuxostat Tablets 80 Mg | 9 | 9.3 | 9.3 |
| Basiliximab | 10 | 9.0 | 9.0 |
| Iron Sucrose | 8 | 8.9 | 8.9 |
| Vemurafenib | 10 | 8.8 | 8.8 |
| Clopidogrel Bisulfate | 82 | 8.8 | 8.8 |
| Clopidogrel | 147 | 8.3 | 8.3 |
| Dronedarone | 8 | 8.3 | 8.3 |
| Erlotinib Hydrochloride | 9 | 7.6 | 7.6 |
| Tranexamic Acid | 6 | 7.1 | 7.1 |
| Emicizumab | 8 | 6.8 | 6.8 |
| Brimonidine Tartrate | 11 | 6.5 | 6.5 |
| Sotalol Hydrochloride | 10 | 6.3 | 6.4 |
| Febuxostat | 10 | 6.3 | 6.3 |
| Prasugrel Hydrochloride | 6 | 6.2 | 6.2 |
| Gemcitabine Hydrochloride | 31 | 6.2 | 6.2 |
| Suvorexant | 7 | 5.7 | 5.7 |
| Erlotinib | 5 | 5.4 | 5.4 |
| Lenvatinib | 16 | 5.2 | 5.2 |
| Brentuximab Vedotin | 5 | 5.1 | 5.1 |
| Ticagrelor | 14 | 4.6 | 4.6 |
| Atezolizumab | 17 | 4.6 | 4.6 |
| Ipilimumab | 18 | 4.4 | 4.4 |
| Tolvaptan | 6 | 4.4 | 4.4 |
| Gemcitabine | 16 | 4.3 | 4.3 |
| Encorafenib | 4 | 4.3 | 4.3 |
| Irinotecan Hydrochloride | 5 | 4.1 | 4.1 |
| Trametinib | 9 | 3.9 | 3.9 |
| Docetaxel Anhydrous | 24 | 3.8 | 3.8 |
| Docetaxel | 24 | 3.8 | 3.8 |
| Pembrolizumab | 37 | 3.7 | 3.7 |
| Acalabrutinib | 4 | 3.5 | 3.5 |
| Nivolumab | 30 | 3.3 | 3.3 |
| Ambrisentan | 31 | 2.6 | 2.6 |